Mainz Biomed N.V. - Ordinary Shares (NQ:MYNZ)

Mainz Biomed Announces Closing of $5.0 million Registered Direct Offering

November 15, 2023

U.S. stocks traded mixed toward the end of trading, with the Dow Jones gaining around 50 points on Monday. The Dow traded up 0.16% to 34,337.33 while the NASDAQ fell 0.11% to 13,783.41. The S&P 500...

12 Health Care Stocks Moving In Tuesday's Intraday Session

November 14, 2023

Via Benzinga

Crude Oil Gains Over 1%; US Budget Deficit Narrows For October

November 13, 2023

Via Benzinga

Topics Stocks

Why Edible Garden Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session

November 13, 2023

Edible Garden AG Incorporated (NASDAQ: EDBL) shares fell on Monday following third-quarter results.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session

November 13, 2023

Via Benzinga

Why Mainz Biomed (MYNZ) Stock Is Getting Hammered

November 13, 2023

Mainz Biomed NV (NASDAQ: MYNZ) shares are trading lower by 46% to $1.21 during Monday's session has entered a securities purchase agreement with institutional investors to raise $5 million through a

Via Benzinga

Dow Surges 100 Points; Tenax Therapeutics Shares Spike Higher

November 13, 2023

U.S. stocks traded mostly higher midway through trading, with the Dow Jones gaining around 100 points on Monday. The Dow traded up 0.33% to 34,397 while the NASDAQ fell 0.06% to 13,790. The S&P 500...

Via Benzinga

Topics Stocks

US Stocks Fall; Tyson Foods Posts Upbeat Earnings

November 13, 2023

U.S. stocks traded lower this morning, with the Nasdaq Composite falling around 100 points on Monday. Following the market opening Monday, the Dow traded down 0.08% to 34,254.53 while the NASDAQ fell...

Via Benzinga

Topics Stocks

Mainz Biomed Announces Pricing of $5.0 million Registered Direct Offering

November 13, 2023

Mainz Biomed Partners With Liquid Biosciences In Exclusive Relationship To Harness The Power Of Artificial Intelligence (AI) To Develop Next-Generation Colorectal Screening Test

November 13, 2023

The integration of Artificial Intelligence (AI) in biotechnology is rapidly gaining momentum, revolutionizing the field of life sciences. AI technologies, such as machine learning and deep learning...

Via Benzinga

Topics Artificial Intelligence

Mainz Biomed Partners with Liquid Biosciences to Harness the Power of Artificial Intelligence (AI) to Develop Next-generation Colorectal Screening Test

November 09, 2023

Collaboration to utilize cutting-edge AI analysis platform for clinical trials and cancer screening test processing

Mainz Biomed’s (NASDAQ: MYNZ) ColoFuture Study Reveals “Groundbreaking Results”: ColoAlert® Raises The Bar For Colorectal Cancer Detection

November 08, 2023

--News Direct--

Via News Direct

Topics Death

AI Meets Oncology! Mainz Biomed Inks Pact With Liquid Biosciences To Develop Next-Gen Colorectal Cancer Screening Test

November 07, 2023

Mainz Biomed N.V. (NASDAQ: MYNZ) inked a pact with Liquid Biosciences, a bio-analytics company leveraging its proprietary AI analysis technology platform (EMERGE), to enhance the

Via Benzinga

Topics Artificial Intelligence

BioNTech Shifted Its Focus To Innovative Oncology And Mainz Biomed Announced A Showcasing Of Its Revolutionary Colorectal Cancer Detection Test

November 07, 2023

On November 6th, BioNTech SE (NASADQ: SE) who partnered with Pfizer Inc (NYSE: PFE) in the making of a blockbuster COVID-19 vaccine, posted a surprise earnings with its latest quarterly report.

Via Benzinga

Mainz Biomed to Showcase ColoAlert® at Leading Global Healthcare Event, MEDICA

November 07, 2023

Mainz Biomed's (NASDAQ: MYNZ) ColoFuture Study Reveals "Groundbreaking Results": ColoAlert® Raises The Bar For Colorectal Cancer Detection

November 07, 2023

Throughout the world, colorectal cancer has emerged as the third most prevalent form of cancer.

Via Benzinga

Splunk Layoffs 2023: What to Know About the Latest SPLK Job Cuts

November 01, 2023

Splunk layoffs are on the way for 7% of the cybersecurity company's global employees as it continues a restructuring plan.

WeWork stock is falling on Wednesday as investors in WE shares react to reports that the company is considering a bankruptcy filing.

Topics Workforce

Why Is WeWork (WE) Stock Down 38% Today?

November 01, 2023

Paycom Software stock is falling hard on Wednesday as investors in PAYC go over the company's mixed earnings report for Q3 2023!

Topics Bankruptcy

Why Is Paycom Software (PAYC) Stock Down 39% Today?

November 01, 2023

Mainz Biomed stock is on the move Wednesday as investors in MYNZ react to results from a colorectal cancer screening test campaign.

Why Is Mainz Biomed (MYNZ) Stock Moving Today?

November 01, 2023

We're starting off Wednesday with a breakdown of the biggest pre-market stock movers investors will want to keep track of today!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

November 01, 2023

Today's Pharma Tales Of Loss And Success: Pfizer Swings To A Quarterly Loss And Mainz Biomed Reports Positive Interim Screening Campaign Results

October 31, 2023

As it struggles to navigate the rapid decline of its Covid-19 fame, Pfizer Inc (NYSE: PFE) reported a quarterly loss for the third quarter.

Via Benzinga

Mainz Biomed Reports Success from Employee Colorectal Cancer Screening Campaign in Partnership with Zöller-Kipper

October 31, 2023

Almost half of Zöller-KipperGmbH’s employees in Germany participated in the screening program so far using ColoAlert®, Mainz Biomed’s user-friendly, at-home colorectal cancer (CRC) screening test

Mainz Biomed Appoints Tarrin Khairi-Taraki as VP of Commercial Operations

October 26, 2023

Mainz Biomed Presents Groundbreaking Results of ColoFuture Study

October 18, 2023

Johnson & Johnson (NYSE: JNJ) reported its third quarter results that topped Wall Street’s expectations while also lifting its full year guidance fueled by a strong performance of its pharmaceutical...

Johnson & Johnson Was Saved By Its Focus On MedTech And Innovative Medicine

October 17, 2023

Via Benzinga

Mainz Biomed to Showcase ColoAlert® at UEG Week 2023 in Copenhagen, Denmark

October 11, 2023

Mainz Biomed team members will be available throughout the event at the Company’s booth located in Hall C, Stand C3-92

As the word itself says, biotechnology is simply technology based on biology. It uses the knowledge of cellular and biomolecular processes to develop technologies that improve our lives and overall...

Big Pharma Could Transform Into BioTech Pharma

October 10, 2023

Via Benzinga

Mainz Biomed to Attend the JonesTrading 2023 Healthcare Summit

October 05, 2023